Journal article
The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis
Vinayak Singh, Stefano Donini, Angela Pacitto, Claudia Sala, Ruben C Hartkoorn, Neeraj Dhar, Gyorgy Keri, David B Ascher, Guillaume Mondesert, Anthony Vocat, Andreanne Lupien, Raphael Sommer, Helene Vermet, Sophie Lagrane, Joe Buechler, Digby F Warner, John D McKinney, Janos Pato, Stewart T Cole, Tom L Blundell Show all
ACS Infectious Diseases | AMER CHEMICAL SOC | Published : 2017
Grants
Awarded by European Community
Awarded by Senior International Research Scholar's grant from the HHMI
Awarded by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)
Awarded by NHMRC CJ Martin Fellowship
Awarded by Swiss National Science Foundation
Awarded by Medical Research Council
Funding Acknowledgements
This work was funded by the European Community's Seventh Framework Programme (Grant 260872); the South African Medical Research Council (to V.M.); the National Research Foundation of South Africa (to V.M.); a Senior International Research Scholar's grant from the HHMI (Grant 55007649 to V.M.); the Bill and Melinda Gates Foundation (to A.P. and T.L.B.), a Newton Fund RCUK-CONFAP grant awarded by The Medical Research Council (MRC) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) (Grant MR/M026302/1 to T.L.B. and D.B.A.), a NHMRC CJ Martin Fellowship (Grant APP1072476 to D.B.A.); the Swiss National Science Foundation (31003A-162641) and the Fondation Beytout (to S.T.C.); the University of Cambridge and The Wellcome Trust for facilities and support (to T.L.B.).